Kristian A Groth1,2, Kirstine Stochholm3,4, Hanne Hove5,6, Kasper Kyhl7, Pernille A Gregersen3,8, Niels Vejlstrup7, John R Østergaard3, Claus H Gravholt9,4, Niels H Andersen10. 1. Department of Cardiology, Aarhus University Hospital, 8200, Aarhus N, Denmark. kristian.groth@ki.au.dk. 2. Department of Molecular Medicine, Aarhus University Hospital, 8200, Aarhus N, Denmark. kristian.groth@ki.au.dk. 3. Centre for Rare Diseases, Department of Pediatrics, Aarhus University Hospital, 8200, Aarhus N, Denmark. 4. Department of Endocrinology and Internal Medicine, Aarhus University Hospital, 8000, Aarhus C, Denmark. 5. Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet, 2100, Copenhagen, Denmark. 6. The RAREDIS Database, Section of Rare Diseases, Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet, 2100, Copenhagen, Denmark. 7. Department of Cardiology, Rigshospitalet, 2100, Copenhagen, Denmark. 8. Department of Clinical Genetics, Aarhus University Hospital, 8200, Aarhus N, Denmark. 9. Department of Molecular Medicine, Aarhus University Hospital, 8200, Aarhus N, Denmark. 10. Department of Cardiology, Aarhus University Hospital, 8200, Aarhus N, Denmark.
Abstract
BACKGROUND: Marfan syndrome is associated with morbidity and mortality due to aortic dilatation and dissection. Preventive aortic root replacement has been the standard treatment in Marfan syndrome patients with aortic dilatation. In this study, we present aortic event data from a nationwide Marfan syndrome cohort. METHOD: The nationwide cohort of Danish Marfan syndrome patients was established from the Danish National Patient Registry and the Cause of Death Register, where we retrieved information about aortic surgery and dissections. We associated aortic events with age, sex, and Marfan syndrome diagnosis prior or after the first aortic event. RESULTS: From the total cohort of 412 patients, 150 (36.4 %) had an aortic event. Fifty percent were event free at age 49.6. Eighty patients (53.3 %) had prophylactic surgery and seventy patients (46.7 %) a dissection. The yearly event rate was 0.02 events/year/patient in the period 1994-2014. Male patients had a significant higher risk of an aortic event at a younger age with a hazard ratio of 1.75 (CI 1.26-2.42, p = 0.001) compared with women. Fifty-three patients (12.9 %) were diagnosed with MFS after their first aortic event which primarily was aortic dissection [n = 44 (83.0 %)]. CONCLUSION: More than a third of MFS patients experienced an aortic event and male patients had significantly more aortic events than females. More than half of the total number of dissections was in patients undiagnosed with MFS at the time of their event. This emphasizes that diagnosing MFS is lifesaving and improves mortality risk by reducing the risk of aorta dissection.
BACKGROUND:Marfan syndrome is associated with morbidity and mortality due to aortic dilatation and dissection. Preventive aortic root replacement has been the standard treatment in Marfan syndromepatients with aortic dilatation. In this study, we present aortic event data from a nationwide Marfan syndrome cohort. METHOD: The nationwide cohort of Danish Marfan syndromepatients was established from the Danish National Patient Registry and the Cause of Death Register, where we retrieved information about aortic surgery and dissections. We associated aortic events with age, sex, and Marfan syndrome diagnosis prior or after the first aortic event. RESULTS: From the total cohort of 412 patients, 150 (36.4 %) had an aortic event. Fifty percent were event free at age 49.6. Eighty patients (53.3 %) had prophylactic surgery and seventy patients (46.7 %) a dissection. The yearly event rate was 0.02 events/year/patient in the period 1994-2014. Male patients had a significant higher risk of an aortic event at a younger age with a hazard ratio of 1.75 (CI 1.26-2.42, p = 0.001) compared with women. Fifty-three patients (12.9 %) were diagnosed with MFS after their first aortic event which primarily was aortic dissection [n = 44 (83.0 %)]. CONCLUSION: More than a third of MFSpatients experienced an aortic event and male patients had significantly more aortic events than females. More than half of the total number of dissections was in patients undiagnosed with MFS at the time of their event. This emphasizes that diagnosing MFS is lifesaving and improves mortality risk by reducing the risk of aorta dissection.
Authors: Raimund Erbel; Victor Aboyans; Catherine Boileau; Eduardo Bossone; Roberto Di Bartolomeo; Holger Eggebrecht; Arturo Evangelista; Volkmar Falk; Herbert Frank; Oliver Gaemperli; Martin Grabenwöger; Axel Haverich; Bernard Iung; Athanasios John Manolis; Folkert Meijboom; Christoph A Nienaber; Marco Roffi; Hervé Rousseau; Udo Sechtem; Per Anton Sirnes; Regula S von Allmen; Christiaan J M Vrints Journal: Eur Heart J Date: 2014-08-29 Impact factor: 29.983
Authors: Alexander W den Hartog; Romy Franken; Aeilko H Zwinderman; Janneke Timmermans; Arthur J Scholte; Maarten P van den Berg; Vivian de Waard; Gerard Pals; Barbara J M Mulder; Maarten Groenink Journal: J Am Coll Cardiol Date: 2015-01-27 Impact factor: 24.094
Authors: Joel Price; J Trent Magruder; Allen Young; Joshua C Grimm; Nishant D Patel; Diane Alejo; Harry C Dietz; Luca A Vricella; Duke E Cameron Journal: J Thorac Cardiovasc Surg Date: 2015-10-27 Impact factor: 5.209
Authors: Morten Schmidt; Sigrun Alba Johannesdottir Schmidt; Jakob Lynge Sandegaard; Vera Ehrenstein; Lars Pedersen; Henrik Toft Sørensen Journal: Clin Epidemiol Date: 2015-11-17 Impact factor: 4.790
Authors: Peggy Robinet; Dianna M Milewicz; Lisa A Cassis; Nicholas J Leeper; Hong S Lu; Jonathan D Smith Journal: Arterioscler Thromb Vasc Biol Date: 2018-01-04 Impact factor: 8.311
Authors: Hector W L de Beaufort; Santi Trimarchi; Amit Korach; Marco Di Eusanio; Dan Gilon; Daniel G Montgomery; Arturo Evangelista; Alan C Braverman; Edward P Chen; Eric M Isselbacher; Thomas G Gleason; Carlo De Vincentiis; Thoralf M Sundt; Himanshu J Patel; Kim A Eagle Journal: Ann Cardiothorac Surg Date: 2017-11
Authors: William C Frankel; Barbara W Trautner; Andrew Spiegelman; Larissa Grigoryan; Scott A LeMaire Journal: Antimicrob Agents Chemother Date: 2019-01-29 Impact factor: 5.191
Authors: Niels H Andersen; Kristian A Groth; Agnethe Berglund; Hanne Hove; Claus H Gravholt; Kirstine Stochholm Journal: Clin Res Cardiol Date: 2021-04-22 Impact factor: 5.460
Authors: Marcel Hanisch; Sabrina Wiemann; Susanne Jung; Johannes Kleinheinz; Lauren Bohner Journal: Int J Environ Res Public Health Date: 2018-10-27 Impact factor: 3.390